End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.69 CNY | +0.04% | -4.71% | -1.19% |
May. 16 | Hengrui Pharmaceuticals Plans Up to 1.2 Billion Yuan Share Buyback | MT |
May. 15 | Hengrui Pharmaceuticals Unit Gets China Clinical Trial Approval for Kidney Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.19% | 39.33B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Hengrui Pharmaceuticals Gets Nod for Taglidine Fumarate Injection